Efficacy and Safety of LAIS® Mites Sublingual Tablets

NCT02277483 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Allergic Conditions

Interventions

DRUG: LAIS®

Sponsor

Ajou University School of Medicine